Companies: 48,687 Total Market Cap: 127281996338110.52

DiaSorin S.p.A.

BIT-DIA

Healthcare Diagnostics & Research

Rank #2688

Market Cap 6.03 B

Volume 179,562.05

Price 111.82

Change (%) 1.49%

Country or region

Italy

DiaSorin S.p.A.'s latest marketcap:

6.03 B

As of May 4, 2025, DiaSorin S.p.A.'s market capitalization has reached $6.03 B. According to our data, DiaSorin S.p.A. is the 2688th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap	6.03 B
Revenue (ttm)	1.34 B
Net Income (ttm)	212.47 M
Shares Out	53.89 M
EPS (ttm)	3.80
Forward PE	22.68
Ex-Dividend Date	May 19, 2025
Earnings Date	May 6, 2025

Market Cap Chart

Data Updated: May 4, 2025

DiaSorin S.p.A.'s yearly market capitalization.

DiaSorin S.p.A. has seen its market value drop from €9.29 B to €5.28 B since 2020, representing a total decrease of 43.19% and an annual compound decline rate (CAGR) of 12.33%.

Date	Market Cap	Change (%)
April 17, 2025	€5.28 B	-0.58%
December 30, 2024	€5.31 B	6.83%
December 29, 2023	€4.97 B	-28.63%
December 30, 2022	€6.96 B	-24.02%
December 30, 2021	€9.16 B	-1.36%
December 30, 2020	€9.29 B

Company Profile

About DiaSorin S.p.A.

DiaSorin S.p.A. is a leading global company specializing in the development, manufacturing, and distribution of immunodiagnostic and molecular diagnostic testing kits. Operating across Europe, North America, and international markets, the company plays a pivotal role in advancing diagnostic solutions.

Key Products & Technologies

LIAISON Chemiluminescence Analyzers: Including the LIAISON XL and LIAISON XS systems for high-performance immunodiagnostic testing.
Simplexa Congenital CMV Direct Kit: A cutting-edge molecular diagnostic tool designed to detect cytomegalovirus (CMV) DNA in saliva swab and urine specimens.

Company Background

Founded in 1968, DiaSorin is headquartered in Saluggia, Italy. With decades of expertise, the company continues to innovate in the diagnostics industry, delivering reliable and efficient testing solutions worldwide.

Frequently Asked Questions

As of May 4, 2025, DiaSorin S.p.A. (including the parent company, if applicable) has an estimated market capitalization of $6.03 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

DiaSorin S.p.A. global market capitalization ranking is approximately 2688 as of May 4, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region	Italy
Founded	1968
IPO Date	n/a
Employees	3,308
CEO	Carlo Rosa
Sector	Healthcare
Industry	Diagnostics & Research
Address	Via Crescentino snc Saluggia, Vercelli 13040 Italy